Logo
x

Search

Subscribe Now

Breakthrough Designation

PharmaShots Interview: BoneHealth Technologies' Laura Yecies Shares Insights on OsteoBoost Vibration Belt

PharmaShots Interview: BoneHealth Technologies' Laura Yecies Shares Insights on OsteoBoost Vibration Belt

  • February 2, 2021
Novartis' Ligelizumab (QGE031) Receives the US FDA's Breakthrough Designation for Patients with Chronic Spontaneous Urticaria

Novartis' Ligelizumab (QGE031) Receives the US FDA's Breakthrough Designation for Patients with Chronic Spontaneous Urticaria

  • January 15, 2021
Inventiva's Lanifibranor Receives the US FDA's Breakthrough Designation for the Treatment of NASH

Inventiva's Lanifibranor Receives the US FDA's Breakthrough Designation for the Treatment of NASH

  • October 12, 2020
PharmaShots' Key Highlights of First Quarter 2019

PharmaShots' Key Highlights of First Quarter 2019

  • August 4, 2019
Nektar and BMS Receive the US FDA's Breakthrough Designation for Bempegaldesleukin (NKTR-214) + Opdivo (nivolumab) to Treat Advanced Melanoma

Nektar and BMS Receive the US FDA's Breakthrough Designation for Bempegaldesleukin (NKTR-214) + Opdivo (nivolumab) to Treat Advanc...

  • August 2, 2019
Merck and Eisai's Dual Regimen Receives the US FDA's Breakthrough Therapy Designation as 1L Treatment for Advanced Unresectable Hepatocellular Carcinoma

Merck and Eisai's Dual Regimen Receives the US FDA's Breakthrough Therapy Designation as 1L Treatment for Advanced Unresectable He...

  • July 23, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.